Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Mar 15, 2004; 10(6): 825-829
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.825
Figure 2
Figure 2 Cumulative survival curves for patients with HCC and APS in two therapeutic groups are shown. The survival rates for patients in the ethanol group were significantly higher than those in the Gelfoam group (P < 0.05).